Skip to content

Acupuncture in Fibromyalgia

Pilot Study of Acupuncture in Fibromyalgia

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00010504
Enrollment
Unknown
Registered
2001-02-05
Start date
2000-08-31
Completion date
2003-07-31
Last updated
2008-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia, Pain

Keywords

acupuncture, fibromyalgia, pain, analgesia

Brief summary

Fibromyalgia is the second most common rheumatic disorder, affecting approximately 8-10 million persons in the U.S., and is characterized by widespread musculoskeletal pain and soft tissue tenderness upon examination. This study focuses on the use of acupuncture as a mode of therapy for fibromyalgia. The issues under examination are: 1) the optimal duration of treatment, 2) the independent and synergistic effects of needle placement and needle stimulation, and 3) appropriate control strategies. The proposal utilizes a randomized, blinded, sham-controlled design to achieve these aims. Subjects are randomly assigned to one of four groups: 1)active site with stimulation, 2) active site, without stimulation, 3) sham site with stimulation, and 4) sham site, without stimulation. All subjects will receive acupuncture at escalating frequency, beginning at once per week and ending at 3 times per week. This forced titration design allows for the detection of inter-subject differences in responsiveness to acupuncture, as well as the factors which may predict responsiveness (or lack thereof). Secondary goals of the study are to collect data on the mechanism, safety, and cost-effectiveness of acupuncture in fibromyalgia, and to determine the optimal outcome measures, for a full scale research clinical trial.

Interventions

PROCEDUREAcupuncture

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Must be a resident of the Washington DC area. * Having met ACR criteria for fibromyalgia. * Continued widespread pain for more than 50% of days. * Willing to limit the introduction of any new medications or treatment modalities for control of fibromyalgia symptoms during the 13 weeks of active treatment. * Able to travel to acupuncture site up to 3 times per week. * Capable of giving informed consent.

Exclusion criteria

* Knowledge of acupuncture sufficient to prevent blinding of the subject. * Presence of a known coagulation abnormality that would prevent safe use of acupuncture. * Presence of a concurrent autoimmune or inflammatory disease that causes pain. * Routine daily use of narcotic analgesics or history of substance abuse. * Participation in other concurrent therapeutic trials. * Pregnant or nursing mothers. * Disability insurance payments. * Ongoing litigation related to fibromyalgia. * Contraindication for the use of acetaminophen or ibuprofen. * Any impairment, activity, or situation that in the judgement of the Study Coordinator would prevent satisfactory completion of the study protocol.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026